Reply to the letter to the editor 'management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015' by Gillessen et al

Ann Oncol. 2015 Nov;26(11):2354-5. doi: 10.1093/annonc/mdv360. Epub 2015 Sep 7.

Authors

S Gillessen¹, S Fanti², A Omlin³; panelists and authors of APCCC

Affiliations

¹ Department of Oncology/Hematology, Kantonsspital St Gallen, St Gallen, Switzerland silke.gillessen@kssg.ch.
² Department of Nuclear Medicine, Policlinico S. Orsola-University of Bologna, Bologna, Italy.
³ Department of Oncology/Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.

PMID: 26347101
DOI: 10.1093/annonc/mdv360

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma / therapy*
Androgen Antagonists / therapeutic use*
Antineoplastic Agents, Hormonal / therapeutic use*
Bone Density Conservation Agents / therapeutic use*
Humans
Male
Prostatic Neoplasms / therapy*
Prostatic Neoplasms, Castration-Resistant / therapy*
Taxoids / therapeutic use*

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal
Bone Density Conservation Agents
Taxoids